Search Within

Renier J Brentjens

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (23)
  3. Review (1)
Groups
  1. Adult Leukemia (55)
  2. Center for Hematologic Malignancies (55)
  3. Department of Medicine (55)
  4. GSK Faculty (55)
  5. Hematologic Malignancies Research (55)
  6. Hematologic Malignancies, Division of (55)

More Groups

People
  1. Terence Purdon (23)
  2. Hollie Pegram (19)
  3. Sarwish Rafiq (15)
  4. Jae Park (12)
  5. Isabelle Riviere (11)
  6. Kevin Curran (10)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (4)
  4. 2020 (8)
  5. 2019 (4)
  6. 2018 (9)

More Years

Publications
  1. Blood (15)
  2. Molecular Therapy (5)
  3. Journal of Clinical Oncology (3)
  4. Bone Marrow Transplantation (2)
  5. Cancer Discovery (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (14)
  3. American Association for Cancer Research (6)
  4. American Society of Clinical Oncology (3)
  5. Cell Press (3)
  6. Elsevier Inc. (3)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Targeted cellular micropharmacies: Cells engineered for localized drug delivery
    Review

    Gardner, T. J.; Bourne, C. M.; Dacek, M. M.; Kurtz, K.; Malviya, M.; Peraro, L.; Silberman, P. C.; Vogt, K. C.; Unti, M. J.; Brentjens, R.; more...
    Cancers (2020)

    Fulltext@MSK | Save
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Engineering armored TCR-modified T cells to enhance anti-tumor efficacy
    Meeting Abstract

    Drakes, D. J.; Rafiq, S.; Purdon, T.; Brentjens, R.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Application of CAR T cells for the treatment of solid tumors
    Journal Article

    Khan, J. F.; Khan, A. S.; Brentjens, R. J.
    Progress in Molecular Biology and Translational Science (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
    Journal Article

    Jin, C. H.; Xia, J.; Rafiq, S.; Huang, X.; Hu, Z.; Zhou, X.; Brentjens, R. J.; Yang, Y. G.
    EBioMedicine (2019)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Seshan, V.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save